Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096086276> ?p ?o ?g. }
- W3096086276 abstract "Abstract Activating alterations of the MET gene are well-characterized oncogenic drivers, and MET inhibitors could successfully treat several tumor types with MET alterations, including gliomas with PTPRZ1-MET fusion. However, the full diversity and prevalence of MET alterations in gliomas are still lacking to accurately identify a subset of patients likely to benefit from MET inhibitor treatment. Here, we interrogated genomic profiles of 1,351 gliomas, and further identify 60 cases harboring MET alterations, including MET fusions and various MET exon skipping events. MET RNA alterations, but not MET amplification, are highly enriched in the secondary glioblastomas (sGBM) with significantly worse prognosis. Further molecular analysis has shown that MET RNA alterations acting an additive effects of MET overexpression are induced in the course of glioma evolution. In vitro and clinical studies indicate cells and patients harboring MET alterations have better response to MET inhibitors. Collectively, these data suggest that a subgroup of gliomas harboring MET alterations likely to have benefit from MET-targeted therapy." @default.
- W3096086276 created "2020-11-09" @default.
- W3096086276 creator A5001711651 @default.
- W3096086276 creator A5004949006 @default.
- W3096086276 creator A5005958218 @default.
- W3096086276 creator A5007992547 @default.
- W3096086276 creator A5010336012 @default.
- W3096086276 creator A5010406647 @default.
- W3096086276 creator A5012326926 @default.
- W3096086276 creator A5023964547 @default.
- W3096086276 creator A5025225927 @default.
- W3096086276 creator A5039882839 @default.
- W3096086276 creator A5042973046 @default.
- W3096086276 creator A5043379516 @default.
- W3096086276 creator A5048379858 @default.
- W3096086276 creator A5052267876 @default.
- W3096086276 creator A5060887873 @default.
- W3096086276 creator A5070697945 @default.
- W3096086276 creator A5074695215 @default.
- W3096086276 creator A5076699095 @default.
- W3096086276 creator A5077204135 @default.
- W3096086276 creator A5079262508 @default.
- W3096086276 creator A5082065346 @default.
- W3096086276 creator A5082515921 @default.
- W3096086276 creator A5087648864 @default.
- W3096086276 date "2020-11-02" @default.
- W3096086276 modified "2023-10-05" @default.
- W3096086276 title "Extensive MET alterations confer clinical response to MET inhibitors in gliomas" @default.
- W3096086276 cites W2085040479 @default.
- W3096086276 cites W2103441770 @default.
- W3096086276 cites W2108234281 @default.
- W3096086276 cites W2168455683 @default.
- W3096086276 cites W2169624569 @default.
- W3096086276 cites W2171385762 @default.
- W3096086276 cites W2179438025 @default.
- W3096086276 cites W2184483246 @default.
- W3096086276 cites W2259572413 @default.
- W3096086276 cites W2295059886 @default.
- W3096086276 cites W2337209831 @default.
- W3096086276 cites W2366536035 @default.
- W3096086276 cites W2410468716 @default.
- W3096086276 cites W2417340969 @default.
- W3096086276 cites W2739147644 @default.
- W3096086276 cites W2802818144 @default.
- W3096086276 cites W2806705819 @default.
- W3096086276 cites W2896599301 @default.
- W3096086276 cites W2921707334 @default.
- W3096086276 cites W2949032010 @default.
- W3096086276 cites W2949398488 @default.
- W3096086276 cites W2980663762 @default.
- W3096086276 cites W2984912591 @default.
- W3096086276 cites W3012023838 @default.
- W3096086276 cites W3013519926 @default.
- W3096086276 cites W3023801326 @default.
- W3096086276 doi "https://doi.org/10.1101/2020.11.02.364711" @default.
- W3096086276 hasPublicationYear "2020" @default.
- W3096086276 type Work @default.
- W3096086276 sameAs 3096086276 @default.
- W3096086276 citedByCount "0" @default.
- W3096086276 crossrefType "posted-content" @default.
- W3096086276 hasAuthorship W3096086276A5001711651 @default.
- W3096086276 hasAuthorship W3096086276A5004949006 @default.
- W3096086276 hasAuthorship W3096086276A5005958218 @default.
- W3096086276 hasAuthorship W3096086276A5007992547 @default.
- W3096086276 hasAuthorship W3096086276A5010336012 @default.
- W3096086276 hasAuthorship W3096086276A5010406647 @default.
- W3096086276 hasAuthorship W3096086276A5012326926 @default.
- W3096086276 hasAuthorship W3096086276A5023964547 @default.
- W3096086276 hasAuthorship W3096086276A5025225927 @default.
- W3096086276 hasAuthorship W3096086276A5039882839 @default.
- W3096086276 hasAuthorship W3096086276A5042973046 @default.
- W3096086276 hasAuthorship W3096086276A5043379516 @default.
- W3096086276 hasAuthorship W3096086276A5048379858 @default.
- W3096086276 hasAuthorship W3096086276A5052267876 @default.
- W3096086276 hasAuthorship W3096086276A5060887873 @default.
- W3096086276 hasAuthorship W3096086276A5070697945 @default.
- W3096086276 hasAuthorship W3096086276A5074695215 @default.
- W3096086276 hasAuthorship W3096086276A5076699095 @default.
- W3096086276 hasAuthorship W3096086276A5077204135 @default.
- W3096086276 hasAuthorship W3096086276A5079262508 @default.
- W3096086276 hasAuthorship W3096086276A5082065346 @default.
- W3096086276 hasAuthorship W3096086276A5082515921 @default.
- W3096086276 hasAuthorship W3096086276A5087648864 @default.
- W3096086276 hasBestOaLocation W30960862761 @default.
- W3096086276 hasConcept C104317684 @default.
- W3096086276 hasConcept C111829193 @default.
- W3096086276 hasConcept C126322002 @default.
- W3096086276 hasConcept C143998085 @default.
- W3096086276 hasConcept C170493617 @default.
- W3096086276 hasConcept C2776996007 @default.
- W3096086276 hasConcept C2778227246 @default.
- W3096086276 hasConcept C2780467284 @default.
- W3096086276 hasConcept C36823959 @default.
- W3096086276 hasConcept C502942594 @default.
- W3096086276 hasConcept C54355233 @default.
- W3096086276 hasConcept C71924100 @default.
- W3096086276 hasConcept C86803240 @default.
- W3096086276 hasConceptScore W3096086276C104317684 @default.
- W3096086276 hasConceptScore W3096086276C111829193 @default.
- W3096086276 hasConceptScore W3096086276C126322002 @default.